Quoin Pharmaceuticals to Announce First Quarter 2025 Financial Results on Tuesday, May 13, 2025

Rhea-AI Summary

Quoin Pharmaceuticals (NASDAQ: QNRX), a late clinical-stage specialty pharmaceutical company specializing in rare and orphan diseases, has scheduled the release of its Q1 2025 financial results for Tuesday, May 13, 2025, before market opening. The company will provide a comprehensive update including the quarter's key achievements, recent accomplishments, and financial performance for the period ending March 31, 2025.

News Market Reaction

-1.59%

1 alert

-1.59% News Effect

On the day this news was published, QNRX declined 1.59%, reflecting a mild negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

ASHBURN, Va., May 06, 2025 (GLOBE NEWSWIRE) -- Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX) (the "Company" or "Quoin"), a late clinical-stage specialty pharmaceutical company focused on rare and orphan diseases, today announced that it plans to release its financial results for the first quarter ended March 31, 2025, before the market opens on Tuesday, May 13, 2025.

The announcement will include an operational update highlighting key achievements from the quarter, recent accomplishments, and financial highlights.

About Quoin Pharmaceuticals Ltd.
Quoin Pharmaceuticals Ltd. is a late clinical-stage specialty pharmaceutical company focused on developing and commercializing therapeutic products that treat rare and orphan diseases. We are committed to addressing unmet medical needs for patients, their families, communities and care teams. Quoin’s innovative pipeline comprises four products in development that collectively have the potential to target a broad number of rare and orphan indications, including Netherton Syndrome, Peeling Skin Syndrome, Palmoplantar Keratoderma, Scleroderma, Epidermolysis Bullosa and others. For more information, go to: www.quoinpharma.com.

For further information, contact:
Quoin Pharmaceuticals Ltd.
Michael Myers, Ph.D., CEO
mmyers@quoinpharma.com

Investor Relations
PCG Advisory
Jeff Ramson 
jramson@pcgadvisory.com
(646) 863-6341

FAQ

When will Quoin Pharmaceuticals (QNRX) release its Q1 2025 earnings?

Quoin Pharmaceuticals will release its Q1 2025 financial results before the market opens on Tuesday, May 13, 2025.

What is Quoin Pharmaceuticals' (QNRX) business focus?

Quoin Pharmaceuticals is a late clinical-stage specialty pharmaceutical company focused on rare and orphan diseases.

What will be included in Quoin Pharmaceuticals' (QNRX) Q1 2025 earnings release?

The earnings release will include financial results, an operational update highlighting key achievements from the quarter, and recent accomplishments.

What period will Quoin Pharmaceuticals' (QNRX) Q1 2025 financial results cover?

The financial results will cover the first quarter ended March 31, 2025.